Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer

Author： Platz Elizabeth A.   Leitzmann Michael F.   Hollis Bruce W.   Willett Walter C.   Giovannucci Edward  

Publisher： Springer Publishing Company

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.15, Iss.3, 2004-04, pp. : 255-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

By Ahonen M.H.  

Cancer Causes and Control, Vol. 11, Iss. 9, 2000-11 ,pp. : 847-852

Springer Publishing Company

Access to resources Recommend Favorite

Both serum 25‐hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 925-935

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study

By Bilinski K.  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 599-607

Springer Publishing Company

Access to resources Recommend Favorite

Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies

By Wang Dan   Vélez de-la-Paz Omar   Zhai Jun-Xia   Liu Dian-Wu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3509-3517

Springer Publishing Company

Access to resources Recommend Favorite

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

By Platz Elizabeth   Pollak Michael  

Cancer Causes and Control, Vol. 16, Iss. 3, 2005-04 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite